Ranked #4,066 of 8,699 institutional investors
Sio Capital Management, LLC
New York, NY
$424M
US stock portfolio at live prices · today +$1.1M (+0.27%)
Live prices, last trade 10:02 AM ET
- Value at quarter end (Q3 2026)
- $470M
- Change from Q2 2026
- −$113.8M (−19.50%)
- Positions
- 47 · 10 new, 13 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: put options on $58.8M. $46.0M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesGMED 7.78%GSK 7.67%AVR 6.17%SENS 4.77%MRK 4.68%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| GMED Globus Medical, Inc. | 476,109 | $33.0M | 7.78% | Added +58% |
| GSK GSK plc | 671,121 | $32.5M | 7.67% | Added +54% |
| AVR Anteris Technologies Global Corp. | 5,179,464 | $26.2M | 6.17% | Reduced −7% |
| SENS Senseonics Holdings, Inc. | 2,290,860 | $20.2M | 4.77% | Added +44% |
| MRK Merck & Co., Inc. | 145,485 | $19.8M | 4.68% | New |
| REPL Replimune Group, Inc. | 865,331 | $16.9M | 3.98% | New |
| MMS Maximus, Inc. | 268,280 | $16.7M | 3.95% | Reduced −62% |
| SNY Sanofi | 356,182 | $16.6M | 3.93% | Reduced −2% |
| LQDA Liquidia Corporation | 282,000 | $16.1M | 3.81% | New |
| VTRS Viatris Inc. | 755,490 | $15.1M | 3.55% | Reduced −21% |
| IDYA IDEAYA Biosciences, Inc. | 500,117 | $13.2M | 3.12% | Added +4% |
| RLMD Relmada Therapeutics, Inc. | 3,629,844 | $11.1M | 2.63% | Added +262% |
| AVAH Aveanna Healthcare Holdings Inc. | 1,012,102 | $10.9M | 2.58% | Added +174% |
| BMRN BioMarin Pharmaceutical Inc. | 174,311 | $10.7M | 2.52% | New |
| ANIP ANI Pharmaceuticals, Inc. | 146,268 | $10.2M | 2.42% | Added +50% |
| TNGX Tango Therapeutics, Inc. | 428,860 | $9.8M | 2.31% | Added +106% |
| COO The Cooper Companies, Inc. | 158,053 | $9.6M | 2.26% | New |
| CI The Cigna Group | 33,935 | $9.4M | 2.22% | Reduced −41% |
| VIR Vir Biotechnology, Inc. | 873,375 | $7.7M | 1.81% | Reduced −19% |
| CELC Celcuity Inc. | 126,339 | $7.2M | 1.70% | Added +15% |
| RAPP Rapport Therapeutics, Inc. | 291,231 | $6.8M | 1.61% | Reduced −5% |
| ALLO Allogene Therapeutics, Inc. | 9,104,151 | $6.0M | 1.43% | Reduced −32% |
| PTCT PTC Therapeutics, Inc. | 82,900 | $4.9M | 1.15% | New |
| TARA Protara Therapeutics, Inc. | 1,991,339 | $4.8M | 1.13% | Added +4% |
| AQST Aquestive Therapeutics, Inc. | 1,278,056 | $4.6M | 1.09% | Reduced −14% |
| PMVP PMV Pharmaceuticals, Inc. | 3,634,137 | $4.5M | 1.07% | Added +38% |
| QTTB Q32 Bio Inc. | 529,155 | $4.4M | 1.05% | New |
| OKUR OnKure Therapeutics, Inc. | 1,082,965 | $3.0M | 0.71% | Added +0% |
| ANTX AN2 Therapeutics, Inc. | 548,103 | $3.0M | 0.70% | Added +3% |
| SVRA Savara Inc. | 657,104 | $2.9M | 0.69% | Added +6% |
| ZBIO Zenas BioPharma, Inc. | 95,457 | $2.4M | 0.57% | Reduced −54% |
| OVID Ovid Therapeutics Inc. | 1,005,334 | $2.3M | 0.55% | Unchanged |
| SER Serina Therapeutics, Inc. | 2,000,000 | $2.3M | 0.55% | Added +100% |
| IMNM Immunome, Inc. | 132,097 | $2.2M | 0.52% | Added +6% |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 766,364 | $1.9M | 0.44% | New |
| FULC Fulcrum Therapeutics, Inc. | 481,601 | $1.8M | 0.42% | New |
| DRUG Bright Minds Biosciences Inc. | 75,152 | $1.6M | 0.37% | Added +2% |
| ALHC Alignment Healthcare, Inc. | 184,424 | $1.2M | 0.29% | New |
| XLO Xilio Therapeutics, Inc. | 152,464 | $1.2M | 0.27% | Unchanged |
| QTI QT Imaging Holdings, Inc. | 440,446 | $832K | 0.20% | Added +2,791% |
| IBIO iBio, Inc. | 904,268 | $723K | 0.17% | Unchanged |
| TELA TELA Bio, Inc. | 636,300 | $512K | 0.12% | Unchanged |
| ENVB Enveric Biosciences, Inc. | 330,000 | $492K | 0.12% | Added +83% |
| ALGS Aligos Therapeutics, Inc. | 327,237 | $434K | 0.10% | Unchanged |
| EYPT EyePoint, Inc. | 373,666 | $98K | <0.1% | Reduced −40% |
| NMTC NeuroOne Medical Technologies Corporation | 82,767 | $58K | <0.1% | Unchanged |
| MODD Modular Medical, Inc. | 26,190 | $46K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| COR Cencora, Inc. | 173,588 | $59.7M |
| WAY Waystar Holding Corp. | 925,834 | $25.2M |
| ORKA Oruka Therapeutics, Inc. | 177,118 | $16.9M |
| REGN Regeneron Pharmaceuticals, Inc. | 18,000 | $16.9M |
| TYRA Tyra Biosciences, Inc. | 695,315 | $13.9M |
| ZBH Zimmer Biomet Holdings, Inc. | 131,445 | $13.5M |
| ABT Abbott Laboratories | 128,656 | $13.5M |
| BMY Bristol-Myers Squibb Company | 193,500 | $11.5M |
| DNTH Dianthus Therapeutics, Inc. | 59,254 | $5.1M |
| OCUL Ocular Therapeutix, Inc. | 539,493 | $3.2M |
| AORT Artivion, Inc. | 48,481 | $904K |
| SION Sionna Therapeutics, Inc. | 127,808 | $387K |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 130,628 | $251K |